WFC
60
2
PSA
45
2
XRAY
31
2
AON
28
2
DHI
27
-9
DVN
24
2
XEL
51
3
CLX
62
-3
ISRG
66
2
EXR
31
-11
LUV
48
3
NUE
39
2
PBI
32
2
ITW
43
-2
INTC
37
2
AMG
49
14
HUM
29
4
RL
75
2
STI
21
9
TAP
54
-3
WFC
60
2
PSA
45
2
XRAY
31
2
AON
28
2
DHI
27
-9
DVN
24
2
XEL
51
3
CLX
62
-3
ISRG
66
2
EXR
31
-11
LUV
48
3
NUE
39
2
PBI
32
2
ITW
43
-2
INTC
37
2
AMG
49
14
HUM
29
4
RL
75
2
STI
21
9
TAP
54
-3
Financhill
Back

Thomson Reuters 10K Form

Buy
52

TRI
Thomson Reuters

Last Price:
$163.10
Seasonality Move:
4.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRI News And Ratings

See the #1 stock for the next 7 days that we like better than TRI

TRI Financial Statistics

Sales & Book Value

Annual Sales: $6.8B
Cash Flow: $607M
Price / Cash Flow: 36.54
Annual Sales: $26.40
Price / Book: 6.18

Profitability

EPS (TTM): 5.08000
Net Income (TTM): $2.3B
Gross Margin: $5.5B
Return on Equity: 20.26%
Return on Assets: 12.28%

Thomson Reuters Earnings Forecast

Key Thomson Reuters Financial Ratios

  • The Gross Profit Margin over the past 29 years for TRI is 80.94%.
  • The Selling, General & Administrative Expenses for TRI have been equal to 37.28% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 8.79% of Operating Income.
  • The Net Earning history of TRI is 39.67% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 13 years.

Thomson Reuters Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Professional Services
Sector: Industrials
Current Symbol: TRI
CUSIP: 884903
Website: thomsonreuters.com

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 0.94
Quick Ratio: 0.74

Price-to-Earnings

Trailing P/E Ratio: 28.13
Forward P/E Ratio: 40.58

TRI Technical Analysis vs Fundamental Analysis

Buy
52
Thomson Reuters (TRI) is a Buy

Is Thomson Reuters a Buy or a Sell?

  • Thomson Reuters stock is rated a Buy
    The current Thomson Reuters [TRI] share price is $163.15. The Score for TRI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.